Retinitis Pigmentosa Clinical Trials

A listing of Retinitis Pigmentosa medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 136 clinical trials
ATTUNE Revision- Complex Primary in Total Knee Arthroplasty Population

Five-year, Prospective, multi-center, non-randomized, non-controlled study of the ATTUNE Revision total knee prostheses, utilizing the fixed bearing (FB) and rotating platform (RP) tibial

  • 268 views
  • 29 Mar, 2021
  • 41 locations
ATTUNE Revision System in the Revision Total Knee Arthroplasty Population

Five-year, Prospective, multi-center, non-randomized, non-controlled study of the ATTUNE Revision total knee prostheses, utilizing the fixed bearing (FB) and rotating platform (RP) tibial

  • 546 views
  • 30 Mar, 2021
  • 44 locations
A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.

This is A Multi-centre, Single-arm, Prospective, Interventional Study to Assess Efficacy and Safety of Neoadjuvant Hormone Therapy using Zoladex (Goserelin) and Casodex (Bicalutamide) in Patients with Advanced Prostate Cancer Undergoing Radical Prostatectomy, to assess the efficacy by resectability rate of neoadjuvant hormone therapy (NHT) in subjects with advanced prostate cancer.

  • 0 views
  • 20 Jun, 2021
  • 1 location
CB-PRP in Retinitis Pigmentosa

The study will provides the enrollment of patients with genetic retinal dystrophies with primary rod impairment. A subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP) will be performed only in one eye, the other eye will be considered as a control group. A complete morpho-functional ophthalmological evaluation will be …

  • 0 views
  • 27 Jan, 2021
  • 1 location
Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP)

Retinitis pigmentosa (RP) is the most common hereditary retinal disorder (accounts for 20% of children attending blind schools in Pakistan) which causes degeneration of rod and cone

  • 0 views
  • 01 Mar, 2021
  • 1 location
Prospective Natural History Study of Retinitis Pigmentosa

This is natural history study of rods and cones degenerations in patients with Retinitis Pigmentosa (RP) caused by pathogenic mutations in RHO, PDE6A or PDE6B gene mutations.

vision test
other disease
eye exam
  • 3 views
  • 23 Jan, 2021
  • 1 location
BS01 in Patients With Retinitis Pigmentosa

Non-randomized, open label, Phase 1/2 dose escalation study of BS01, a non-replicating, rep/cap-deleted, recombinant adeno-associated virus vector expressing an enhanced light-sensitive channelrhodopsin gene (ChronosFP).

  • 159 views
  • 23 Jan, 2021
  • 1 location
CNS10-NPC for the Treatment of RP

The investigator is examining the safety of transplanting cells into the subretinal space of patients with Retinitis Pigmentosa (RP). The cells are called neural progenitor cells, which are a

electroretinogram
  • 178 views
  • 24 Jan, 2021
  • 1 location
PDE6A Gene Therapy for Retinitis Pigmentosa

curative therapy of PDE6A-linked retinitis pigmentosa in patients, in order to counteract their disease progression and to stop further impairment of visual function. The vector is given with a single

gene therapy
other disease
  • 0 views
  • 26 Jan, 2021
  • 1 location
  • 0 views
  • 22 Jan, 2021
  • 1 location